A detailed history of Prudential Financial Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 25,900 shares of VXRT stock, worth $16,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,900
Previous 25,900 -0.0%
Holding current value
$16,317
Previous $17,000 29.41%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.53 - $1.3 $7,526 - $18,460
14,200 Added 121.37%
25,900 $17,000
Q1 2024

May 14, 2024

BUY
$0.56 - $1.41 $6,552 - $16,497
11,700 New
11,700 $15,000
Q2 2020

Aug 12, 2020

BUY
$1.68 - $8.85 $488,723 - $2.57 Million
290,907 New
290,907 $2.57 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $79.7M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.